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Abstract
The role of mast cells (MCs) in contact hypersensitivity (CHS) remains controversial. This is due in part to the use of the MC-
deficient Kit
W/Wv mouse model, since Kit
W/Wv mice congenitally lack other types of cells as a result of a point mutation in c-
kit. A recent study indicated that the intronic enhancer (IE) for Il4 gene transcription is essential for MCs but not in other cell
types. The aim of this study is to re-evaluate the roles of MCs in CHS using mice in which MCs can be conditionally and
specifically depleted. Transgenic Mas-TRECK mice in which MCs are depleted conditionally were newly generated using cell-
type specific gene regulation by IE. Using this mouse, CHS and FITC-induced cutaneous DC migration were analyzed.
Chemotaxis assay and cytoplasmic Ca
2+ imaging were performed by co-culture of bone marrow-derived MCs (BMMCs) and
bone marrow-derived dendritic cells (BMDCs). In Mas-TRECK mice, CHS was attenuated when MCs were depleted during the
sensitization phase. In addition, both maturation and migration of skin DCs were abrogated by MC depletion. Consistently,
BMMCs enhanced maturation and chemotaxis of BMDC in ICAM-1 and TNF-a dependent manners Furthermore, stimulated
BMDCs increased intracellular Ca
2+ of MC upon direct interaction and up-regulated membrane-bound TNF-a on BMMCs.
These results suggest that MCs enhance DC functions by interacting with DCs in the skin to establish the sensitization phase
of CHS.
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Introduction
Contact hypersensitivity (CHS) has been widely used to study
cutaneous immune responses, since it is a prototype of delayed-type
hypersensitivity mediated by antigen -specific T cells [1,2,3,4]. An
essential step in the sensitization phase for CHS is the migration of
hapten-bearing cutaneous dendritic cells (DCs), such as epidermal
Langerhans cells (LCs) and dermal DCs, into skin-draining lymph
nodes (LNs). After completing their maturation, mature DCs
present antigen to naive T cells in the LNs, thus establishing the
sensitization phase. In the subsequent challenge phase, re-exposure
tothecognate haptenresults intherecruitmentofantigen-specific T
cells and other non-antigen-specific leukocytes.
The functions of cutaneous DCs are modulated by keratinocyte-
derived proinflammatory cytokines [1,5]. The role of the different
skin DC subsets in CHS (inducers, regulators, or functional
redundancy) is a matter of active debate [6]. In addition, dermal
DCs, including Langerin (CD207)
+ dermal DCs, may also play an
important role in CHS [7,8].
Mast cells (MCs) are a candidate DC modulator since they
express and release a wide variety of intermediaries, such as
histamine, tumor necrosis factor (TNF)-a and lipid mediators. It
has been reported that activated human cord blood-derived MCs
induce DC maturation in vitro [9], that IgE-stimulated MC-derived
histamine induces murine LC migration in vivo [10], and that MC-
derived TNF-a promotes cutaneous murine DC migration in vivo
in an IgE-independent manner [11]. On the other hand,
prostaglandin (PG) D2 produced by MCs in response to allergens
[12], inhibits LC migration [13]. Therefore, MCs might have bi-
directional effects on DC activity in a context-dependent manner
and the question of the mechanisms by which DCs are modulated
by MCs is an important issue to pursue.
While MCs have been assumed to play an important role in
CHS, their role is controversial. Previous studies have demon-
strated that MC-deficient Kit
W/Wv mice show attenuated CHS
responses, meanwhile, other studies have shown that CHS was not
impaired in Kit
W/Wv mice [14]. Although some studies indicated
that the discrepancy in W/Wv mice might be due to the difference
in hapten dose, the detailed mechanism is still unclear. Kit
W/Wv
mice and Kit
W-sh/KitW-sh mice have an inversion mutation in the Kit
gene [15], and therefore, these mice also lack melanocytes and
hematopoietic stem cells, which are known to modulate immune
responses [16,17]. In addition, since MCs are congenitally absent,
it is possible that compensatory mechanisms may exist that
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re-evaluate the roles of MCs using mice in which MCs can be
conditionally and specifically depleted.
Recently, we have demonstrated that MCs and basophils use
specific enhancer elements, intronic enhancer (IE) and a 39 4kb
fragment that contains 39UTR and HS4 elements, to regulate Il4
gene expression, respectively [18]. Taking advantage of this
system, we have generated mice that contain human diphtheria
toxin receptor (DTR) under the control of IE. Therefore, mast
cell-specific enhancer-mediated Toxin Receptor-mediated Condi-
tional cell Knock out (TRECK) systems were designated as Mas-
TRECK transgenic (Tg) mice. In these mice, both MCs and
basophils are conditionally depleted by diphtheria toxin (DT)
treatment. Since basophils recover much faster than MCs (Fig
S1A, B), there exist a period of specific MC depletion. Taking
advantage of the system, we have herein demonstrated that
activated DCs induce MC activation, which triggers the migration
and maturation of DCs via cell-cell contact. This DC-MC
interaction plays an essential role in the sensitization phase of
CHS.
Results
Suppression of CHS responses in Mas-TRECK Tg mice
Mice expressing the human DTR under the control of IE
element (for Mas-TRECK) and 39UTR element (for basophil-
specific enhancer-mediated TRECK systems; Bas-TRECK) in the
Il4 gene locus were generated by a transgenic strategy (Sawaguchi
et al. Manuscript in submission). We initially demonstrated that
skin MCs were completely depleted in Mas-TRECK Tg mice 5
and 12 days after an intraperitoneal injection of diphtheria toxin
(DT) (See Fig. S1A in the Online Repository). Although DX5+
FceRIa+ basophils in the blood were eliminated 5 days after DT
treatment in Mas-TRECK Tg mice, basophil numbers recovered
in 12 days (Fig. S1B in the Online Repository).
To investigate the role of MCs in cutaneous acquired immune
responses, we used DNFB-induced CHS as a model. CHS
responses were similar between wild type (WT) and Mas-TRECK
Tg mice in the absence of DT treatment (205 mm610.5 vs
212 mm612.3; average 6 SD). In addition, DT treatment itself
did not affect the degree of CHS responses in WT mice. On the
other hand, when both WT and Mas-TRECK Tg mice were
treated with DT and assayed 12 days later, the CHS response in
Mas-TRECK Tg mice was much less than that in WT mice
(Fig. 1A). The ear swelling of WT and Mas TRECK Tg mice was
48.2 (65.2, SD) mm and 51.3 (64.8, SD) m after 72 h, and 15
(67.29, SD) mm and 40.1 (66.68, SD) mm after 96 h respectively.
Histology of the ears 48 h after the challenge showed considerable
lymphocyte infiltration and edema in the dermis of sensitized WT
mice; these changes were less apparent in Mas-TRECK Tg mice
(Fig. 1B, left panel) and the histological scores [19] in Mas-
TRECK Tg mice were lower than those in WT mice (Fig. 1B,
right panel). On the other hand, the CHS response was not
impaired in Kit
W/Wv mice (See Fig. S2A in the Online
Repository).
In addition, the CHS response in Bas-TRECK Tg mice, which
lack only basophils upon treatment with DT, was similar to that of
WT mice (See Fig. S2B in the Online Repository). The
attenuated CHS response in Mas-TRECK Tg mice was
confirmed using an additional hapten, oxazolone (Fig. 1C) and
also at higher hapten doses (See Fig. S2C in the Online
Repository).
To clarify the action phase of MCs in CHS, we used an
adoptive transfer-induced CHS model. Recipients of LN cells from
sensitized WT mice showed an enhanced CHS response, whereas
the recipients of LN cells from sensitized Mas-TRECK Tg mice
showed a markedly inhibited response (Fig. 1D). In addition, the
recipients of CD90.2+ T cells from sensitized Mas-TRECK Tg
mice showed inhibited responses compared to recipients of
CD90.2+ T cells from sensitized WT mice (See Fig. S2D in the
Online Repository). These data indicate that MCs play important
roles in establishing CHS during the sensitization phase.
We further evaluated whether the attenuated CHS in Mas-
TRECK Tg mice reflected the lack of MCs. WT or Mas-TRECK
Tg mice were engrafted in the skin with or without BMMCs
5610
6 cells in 100 ml/dorsal skin 1 hour before oxazolone
sensitization. The numbers of toluidine blue positive mast cells
(per field) in the dermis are 40.2 (65.3, SD) in Mas TRECK Tg
mice and 35.3 (67.2, SD) in B6 wild type mice after one hour
injection of BMMC (n=3) (See Fig. S2E in the Online
Repository). On the other hand, the number of MCs in the
uninjected sites was 10.5 (63.2, SD) in B6 wild type mice. Five
days after sensitization, the skin-draining LN cells of sensitized
mice were adoptively transferred intravenously into naive WT
recipients and challenged with oxazolone on the ears. The CHS
response of recipients of LN cells from sensitized WT mice was not
changed by the pre-engraftment of BMMCs into the skin
(Fig. 1E). On the other hand, the attenuated CHS response of
recipients of Mas-TRECK Tg LN cells was fully restored by the
pre-engraftment of BMMCs into the skin.
Next we counted the cells infiltrating the skin of WT and Mas-
TRECK Tg mice 12 h after challenge with DNFB. The numbers
of CD45+ CD3+ CD4+ T cells, CD45+ CD3+ CD8+ T cells, and
CD45+ Gr-1high neutrophils after both sensitization and
challenge, and that of neutrophils after only challenge were
increased in WT mice. But such increment was attenuated in Mas-
TRECK Tg mice (See Fig. S3A in the Online Repository).
Consistent with this result, the mRNA levels of IFN-c, IL-17 and
IL-1b in the skin 12 h after challenge were significantly decreased
in Mas-TRECK Tg mice compared to WT mice (See Fig. S3B in
the Online Repository).
We further analyzed the composition of LN cells after
sensitization. Five days after sensitization, the skin-draining LN
cells of WT and Mas-TRECK Tg mice were collected. The
numbers of CD44+ CD62L+ central memory T cells and CD44+
CD62L- effector memory T cells among CD4+ and CD8+ T cell
subsets were less in Mas-TRECK Tg mice than in WT mice (See
Fig. S4A in the Online Repository). In contrast, the numbers
within each subset in the LN without sensitization were
comparable between WT and Mas-TRECK Tg mice (See Fig.
S4A in the Online Repository).
To evaluate of T cell differentiation after sensitization, the skin-
draining LN cells from control or DNFB-sensitized WT and Mas-
TRECK Tg mice were challenged in the presence or absence of
DNBS in vitro. The incorporation of
3H-thymidine and the levels of
IFN-c and IL-17 in the culture supernatant in the presence of
DNBS were markedly decreased in LN cells from Mas-TRECK
Tg mice as compared with those from WT mice (See Fig. S4B-D
in the Online Repository). The levels of IL-4 in the culture
supernatants were below the limit of detection of ELISA
(,0.3 pg/mL).
Attenuated DC migration and maturation in the skin-
draining LNs of Mas-TRECK Tg mice
An essential step in the sensitization phase for CHS is the
migration of hapten-bearing cutaneous dendritic cells (DCs), such
as epidermal Langerhans cells (LCs) and dermal DCs, into skin-
draining lymph nodes (LNs). Accordingly, to dissect the site of
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cutaneous DCs that have an opportunity to interact with MCs
present in the dermis.
Using a FITC-induced cutaneous DC migration model, we
found that the numbers of both FITC
+ CD11c
+ MHC class II
+
CD207
+ DCs and FITC
+ CD11c
+ MHC class II
+ CD207
2 DCs
in the draining LNs 24 h and 72 h after FITC application were
significantly attenuated in Mas-TRECK Tg mice compared to
WT mice (Fig. 2A, B). In addition, the numbers of total CD4
+
and CD8
+ T cells, and CD44
+ CD62L
+ central memory and
CD44
+ CD62L
2 effector memory T cells in the draining LNs of
Mas-TRECK Tg mice were less than those of WT mice (Fig. 2C).
We next analyzed the expression levels of costimulatory molecules
by skin organ culture. We incubated the skin and analyzed the
expression levels on crawl-out DCs in the culture medium. The




+ LCs and CD11c
+ MHC class II
+
EpCAM
2 dermal DCs in Mas-TRECK Tg mice were lower than
those of WT mice (Fig. 2D, E, and see Fig. S5A, upper panel, in
the Online Repository). On the other hand, the expression levels
of costimulatory molecules on LCs and dermal DCs from the
untreated WT controls and Mas TRECK Tg mice were
comparable (See Fig. S5A, lower panel, in the Online
Repository). In addition, the expression levels on LCs and dermal
DCs from WT and Mas-TRECK mice were comparable under
steady state conditions (See Fig. S5B in the Online Repository).
Figure 1. MCs are essential during the sensitization phase in CHS. (A) Twelve days after DT treatment, WT and MaS TRECK Tg mice (n=12 per
group) were sensitized with or without DNFB and the ear swelling was measured 24 and 48 h after challenge with DNFB. (B) HE staining of the ears of
sensitized DT-treated WT and MaS TRECK Tg mice 24 h after challenge with DNFB. Scale bar, 100 mm (left panels) and 200 mm (middle panels).
Samples were scored for the severity and character of the inflammatory response using a subjective grading scale. The total histology score was
calculated as the sum of scores (right panels). (C) Oxazolone-induced CHS in WT (white columns) and Mas-TRECK Tg (grey columns) mice. DT-treated
WT and MaS TRECK Tg mice (n=13 per group) were sensitized with oxazolone and ear swelling measured 24 and 48 hours after challenge with
oxazolone. (D) CHS induced by adoptive transfer of LN cells sensitized with DNFB of WT (white columns) and Mas-TRECK Tg (grey columns) (n=6 per
group). (E) Draining LNs from oxazolone-sensitized WT (white columns) and Mas-TRECK Tg (grey columns) reconstituted with BMMCs (n=5 per
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to those from Kit
W/Wv mice (See Fig. S5B in the Online
Repository).
We further evaluated the effect of MCs on the antigen
presenting capacity of DCs. We sorted 5610
5 T cells by auto
MACS from the draining LNs of CD90.2
+ WT mice five days
after 25 ml of 2% oxazolone application. These CD90.2
+ T cells
were incubated for 72 h with or without CD11c
+ DCs (1610
5
cells) prepared from the draining LNs of WT or Mas-TRECK Tg
mice one day after oxazolone application. T cell proliferation was
enhanced by the addition of antigen-acquired DCs sorted from the
draining LN of sensitized mice, and the extent of augmentation by
DCs from WT mice was much higher than that of DCs from Mas-
TRECK Tg mice (Fig. 2F).
Enhancement of BMDC maturation and chemotaxis by
BMMC requires cell-cell contact in vitro
Impairment of DC functions as a result of MC deficiency
suggests that MCs stimulate cutaneous DCs. To address this
hypothesis, we prepared BMDCs [20] and incubated them with or
without BMMCs. Co-cultivation of BMDCs with BMMCs for
24 h significantly increased the expression levels of CD40, CD80,
CD86 and CCR7 on BMDCs (Fig. 3A). In addition the
chemotaxis of BMDCs to CCL21 was significantly enhanced,
Figure 2. Impaired cutaneous DC migration and maturation in Mas-TRECK Tg mice. (A, B) The numbers of FITC
+ CD11c
+ MHC class II
+
CD207
+ DCs and FITC
+ CD11c
+ MHC class II
+ CD207
2 DCs in the draining LNs of DT-treated MaS TRECK Tg and WT mice 24 h and 72 h after
application of FITC. (C) The numbers of total, central memory (CM), and effector memory (EM) CD4
+ and CD8
+ T cells in the draining LN 72 h after
FITC application are shown. (D, E) The expression levels of CD40, CD80, and CD86 on both LCs and dDCs of DT-treated MaS TRECK Tg and WT mice.
(F) In vitro assay of T-cell proliferation induced by DCs sorted from the draining LN of sensitized mice of WT or Mas-TRECK Tg (Mas) mice. Oxazolone-
sensitized CD90.2
+ T cells were purified from the draining LNs of WT or Mas-TRECK Tg (Mas) mice 5 d after oxazolone application. T cells (5610
5 cells)
were incubated for 72 h, pulsed with 0.5 mCi [
3H]thymidine for the last 24 h ,with or without CD11c
+ DCs (1610
5 cells) prepared from the draining
LNs of DT-treated WT and MaS TRECK Tg mice one day after oxazolone application. All data are presented as the mean 6 SD and are representative
of three experiments.
*, P,0.05 versus a corresponding group.
doi:10.1371/journal.pone.0025538.g002
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(Fig. 3B).
Furthermore addition of BMMCs to the upper chamber of
transwells did not induce further up-regulation of CD40, CD80,
CD86 and CCR7 levels on BMDCs incubated in the lower
chamber (Fig. 3C), which suggests that BMMCs require direct
cell-cell interaction to stimulate BMDCs.
Stimulation of BMMCs by activated BMDCs
We then examined in vitro whether DCs directly contacted MCs.
We incubated BMMCs and BMDCs, and found that c-kit
+
BMMCs contacted MHC class II
+ BMDCs (Fig. 4A). A number
of FceRIa
+ CD11c
2 MCs co-localized with CD11c
+ DCs in ear
dermis 24 h after sensitization with DNFB (Fig. 4B). Consistent
with this, the number of MCs co-located with DCs after
sensitization was higher than that in the steady state (in other
words, in non-inflammatory conditions) (460.81 vs 0.360.58;
average 6 SD).
At present, several stimuli in addition to IgE are known to
trigger calcium influx and activate MCs [21]. Therefore, we
studied the effect of BMDCs on BMMCs using Ca
2+ imaging. We
incubated tetramethylrhodamine ethyl ester (TMRE)-labeled
BMDCs and Fluo-8-labeled BMMCs together. When an intracel-
lular Ca
2+ concentration of Fluo-8 (green) -labeled BMMCs is
upregulated, fluorescence intensity of green becomes increased.
Unstimulated CD11c
+ MHC class II
int+ BMDCs did not increase
BMMC intracellular Ca
2+ concentrations (Fig. 4C, See Video
S1 in the Online Repository). On the other hand, stimulated
CD11c
+ MHC class II
high+ BMDCs induced prominent Ca
2+
increase in BMMCs (Fig. 4D and See Video S2 in the Online
Repository). This rapid rise occurred five to ten times in 1000
seconds, and each spike lasted about 10–20 sec (Fig. 4E).
Stimulated BMDCs significantly upregulated the ratio of BMMCs
with increased Ca
2+ concentration compared to non-stimulated
BMDCs (Fig. 4F). These results suggest that stimulated DCs
activate MCs via direct cell-cell contact.
Stimulation of DCs by MCs is dependent on ICAM-1-LFA-
1 interaction and on MC membrane-bound TNF-a
We then sought to identify how MCs promote DC maturation.
It has been reported that ICAM-1 on the surface of MCs directly
interacts with leukocyte function-associated antigen 1 (LFA-1) on
T cells, and that stimuli such as CD40L, LPS, and TNF-a,
upregulate the expression of ICAM-1 on DCs [22]. In fact, the
expression of ICAM-1 on BMDCs was up-regulated upon
stimulation of BMDCs by LPS and CCL21 (Fig. 5A). Therefore,
we hypothesized that MCs and DCs interact in an ICAM-1- and
LFA-1-dependent manner. Addition of neutralizing anti-ICAM-1
antibody to a culture of BMDCs completely inhibited upregulation
of CD40, CD80 and CD86 expression on BMDCs upon addition
of BMMC (Fig. 5B, S6A).
We then analyzed intracellular signaling using the protein
kinase A inhibitor, H89, and the phosphoinositide 3 kinase
inhibitor, wortmannin. Although H89 did not inhibit the BMMC-
induced upregulation of co-stimulatory molecules on BMDCs,
wortmannin inhibited DC maturation (Fig. 5C, S6B). These
results suggest that binding of ICAM-1 to LFA-1 activates DCs
through a PI3-kinase pathway.
Lastly we tried to identify how DCs induce MC activation.
TNF-a is first produced as a 26 kDa transmembrane molecule
(membrane-bound TNF-a), which is cleaved by the metallopro-
teinase-disintegrin TNF-a converting enzyme TACE [23] to
generate a soluble 17 kDa TNF-a. Studies have shown that
membrane-bound TNF-a is also biologically active [24]. We first
observed that anti-TNF-a antibody completely blocked DC
maturation induced by BMMCs (Fig. 5B). Consistently, BMMC
from TNF-a KO mice did not promote BMDC maturation (Fig.
S6C). But the soluble form of TNF-a in the supernatant of co-
cultures of BMMCs and TNF-a KO-derived BMDCs was below
the detection limit irrespective of BMDC stimulation (,8 pg/ml,
each). On the other hand, the level of membrane-bound TNF-a
on BMMCs was increased by the addition of BMDCs and even
further enhanced when stimulated BMDCs were added (Fig. 5D).
These results suggest that MCs express membrane-bound TNF-a
upon direct interaction with activated DCs through ICAM-1 on
DCs and that membrane-bound TNF-a induces expression of co-
stimulatory molecules on DCs.
Discussion
In this study, we used Mas-TRECK Tg mice in which MCs can
be eliminated specifically and conditionally, and demonstrated
Figure 3. BMMCs promote the maturation and chemotactic
activity of BMDCs via direct cell interaction. (A) The expression
levels of CD40, CD80, CD86 and CCR7 on BMDCs cultured with or
without BMMCs for 24 h. (B) Mobility of BMMCs to CCL21. BMMCs with
or without BMDCs were applied to the upper chamber of a transwell
without coating for 3 h. The numbers of MHC class II
+ cells in the lower
chamber, identified as migrating DCs, were counted by means of flow
cytometry. (C) The expression levels of CD40, CD80, CD86 and CCR7 on
BMDCs cultured with or without BMMCs separately by using transwell
culture plates for 24 h. All data are presented as the mean 6 SD and are
representative of three experiments.
*, P,0.05 versus a corresponding
group.
doi:10.1371/journal.pone.0025538.g003
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memory T cell induction in skin-draining LNs after sensitization.
MC depletion also impaired hapten-induced cutaneous DC
migration concordant with levels of co-stimulatory molecule
expression. In addition, BMMCs promoted BMDC maturation
and chemotactic activity by direct interaction via ICAM-1 and
membrane-bound TNF-a. In fact, a certain number of DCs were
found colocalized with MCs in the DNFB-sensitized dermis. These
findings suggest that MCs may promote migration and maturation
of dermal DCs and epidermal LCs to establish the sensitization
phase of CHS.
It was previously reported that FITC-induced cutaneous DC
migration was attenuated in Kit
W-sh/KitW-sh mice at 24 h, but not at
48 or 72 h after FITC application, and that the sensitization phase
of CHS was not attenuated in Kit
W-sh/KitW-sh mice [11]. The above
findings were inconsistent with our findings in the way that
cutaneous DC migration was attenuated even at 72 h after FITC
application and that sensitization phase was impaired in Mas-
TRECK Tg mice. On the other hand, it has also been shown that
MCs are capable of influence both the sensitization phase and the
elicitation phase in other models of CHS [25]. Therefore, it still
remains unknown how the discrepancy occurred. The difference
between our model and Kit
W/Wv and Kit
W-sh/KitW-sh mice is the
existence of melanocytes and hematopoietic stem cells. Recently,
melanocytes were shown to express toll like receptors, to modulate
immune responses and to produce IL-1a and IL-1b [16,17]. In
addition, because of congenital absence of MCs in Kit
W/Wv and
Kit
W-sh/KitW-sh mice, compensatory mechanism may exist, such as
repopulation of basophils. In fact, the numbers of basophils have
been counted in these mice; the number of basophils in in Kit
W/Wv
mice are lower than that in WT mice, and that in Kit
W-sh/KitW-sh
mice are higher than that in WT mice [26]. These results indicate
that the compensatory mechanisms may affect the result of CHS
responses and that Kit
W/Wv and Kit
W-sh/KitW-sh mice may not
necessarily be representative to evaluate the roles of pure MCs. In
this study, we have demonstrated that the attenuated CHS
response in Mas TRECK Tg mice was fully restored by the pre-
engraftment of BMMCs into the skin just before sensitization with
Figure 4. Stimulated BMDCs enhance Ca
2+ influx in BMMCs and BMMCs interact with DCs in vitro and in vivo. (A) On poly-L-lysine
coated glass coverslips, c-kit
+ BMMCs (green) contacted MHC class II
+ BMDCs (red). (B) Conjugate formation of CD11c
+ DCs (green) with FceRIa
+ MCs
(red) in the sensitized skin. (C–E) BMMCs (green) were co-cultured with non-stimulated BMDCs (C) or BMDCs stimulated with 100 ng/ml of LPS and
50 ng/ml of CCL21 for 1 h (red; D, E), and the intracellular Ca
2+ was monitored by Fluo-8 for 1200 sec. Photos were taken at the indicated time points
from Supplemental Movie 2 (E). (F) The percentage of BMMCs demonstrating high Ca
2+ concentration among BMMCs. Data are presented as the
mean 6 SD and are representative of three experiments.
*, P,0.05 versus a corresponding group.
doi:10.1371/journal.pone.0025538.g004
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reconstitution with native skin MCs, since freshly generated
BMMC and native skin MCs can differ in aspects of phenotype
and function. We can’t perform long term engraftment of BMMC
in this model because we have found that repeated DT treatment
(more than 5 days of daily injection) leads to weak viability of the
Mas TRECK Tg mice.
We showed that co-culture of DCs with MCs did not promote
soluble TNF-a secretion from MCs but up-regulated membrane-
bound TNF-a on MCs. Since TNF-a expressed on MCs in this
context is membrane-bound, MCs are required to co-localize with
DCs in vivo to elicit its effect. Since neutralizing anti-TNF-a Ab
abrogated the BMMC-induced DC maturation, membrane-bound
TNF-a on MCs might be the major modulator of DC maturation.
Herein we have focused on the roles of MCs in the sensitization
phase, but we also noted that MC depletion in the elicitation phase
attenuated the CHS response. Since DCs are thought to present
antigentomemoryT cellstoinitiatethe challengephaseofCHS,the
interaction of MCs and DCs might be essential for its establishment,
which is a question that will be pursued in a future study.
The direct interaction between DCs and MCs was essential not
only for DC stimulation, but also for MC activation. Previous
reports have demonstrated that MCs contact extracellular matrix
components to provide a co-stimulatory signal for histamine and
cytokine production via integrins [27]. MCs are known to
degranulate upon binding of ICAM-1 on MCs and LFA-1 on
activated T cells [28]. In agreement with this, our study
demonstrates that the interaction of MCs with DCs is dependent
on cell-cell contact via ICAM-1 and LFA-1. In addition, an influx
of calcium in MCs is induced by activated DCs that express high
levels of ICAM-1, but not by immature DCs. Therefore, in
sensitized skin, activated DCs bind to MCs and promote activation
and up-regulating membrane-bound TNF-a on MCs. Activated
MCs further promote additional activation of hapten-bearing
cutaneous DCs causing them to migrate into skin-draining LNs.
These findings indicate that MCs play an essential role in
Figure 5. DC stimulation depends on ICAM-1-LFA-1 signals and membrane-bound TNF-a on MCs. (A) The expression of ICAM-1 on
stimulated or non-stimulated BMDCs. (B, C) The expression levels of CD40, CD80, and CD86 on BMDCs co-cultured with BMMCs with isotype control
Ab (Iso), anti-ICAM-1 Ab (IC), or anti-TNF-a Ab (TNF) (B), or co-cultured with BMMCs that were pretreated with or without wortmannin (WM) or H89
(C). (D) BMMCs expressing membrane-bound TNF-a in the presence of absence of BMDCs with or without stimulation with 100 ng/ml of LPS and
50 ng/ml of CCL21 for 1 h. All data are presented as the mean 6 SD and are representative of three experiments.
*, P,0.05.
doi:10.1371/journal.pone.0025538.g005
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Mice expressing the human DTR under the control of IE
element (for Mas-TRECK) and 39UTR element (for Bas-TRECK)
in the Il4 locus were generated by a transgenic strategy. The basic
pIL-4 construct was made by insertion of the 59enhancer (59E)
(2863 to 25448; start codon is defined as sequence number 0)
[29] and the IL-4 promoter from position 264 to 2827. Human
DTR fragment was isolated from human DTR/pMS7 vector that
was provided by Dr. M. Tanaka (RCAI, RIKEN, Yokohama,
Japan) and inserted into the basic pIL-4 construct. IE (+311 to
+3534) and 39UTR (+6231 to +10678) fragments were isolated
from a mouse YAC clone (catalog no. 95022; Research Genetics,
Huntsville, AL) and inserted into the basic pIL-4 and human DTR
construct respectively. Each transgenic (Tg) line was generated on
a C57BL/6 background. C57BL/6 (B6, WT) mice were
purchased from Japan SLC (Shizuoka, Japan). TNF-a KO mice
on the C57BL/6 background were generated [30]. WBB6F1-
Kit+/+ and –Kit
W/Wv mice were obtained from The Jackson
Laboratory. For DT treatment, mice were injected intraperitone-
ally with 250 ng of DT in 250 ml of PBS per mouse for five
consecutive days. Eight to ten week-old female mice were used for
all the experiments and bred in specific pathogen-free facilities at
Kyoto University. All experimental procedures were approved by
the institutional animal care and use committee of Kyoto
University Graduate School of Medicine (MedKyo11100).
Reagents, antibodies and intracellular staining
We purchased dinitrofluorobenzene (DNFB) from Nacalai
Tesque (Kyoto, Japan), 2,4- dinitrobenzene sulfonic acid (DNBS)
from Alfa Aesar (Ward Hill, MA). FITC-, PE-, PE-Cy5-, PE-Cy7-,
APC-, APC-7-, and Pacific Blue-conjugated 145-2C11 (anti-CD3),
GK1.5 (anti-CD4), 53-6.7 (anti-CD8), N418 (anti-CD11c), 1C10
(anti-CD40), 30-F11 (anti-CD45), 16-10A1 (anti-CD80), GL1
(anti-CD86), M5/114.15.2 (anti-MHC class II), MEL-14 (anti-
CD62L), IM7 (anti-CD44), eBioKAT-1 (anti-intercellular adhe-
sion molecule 1 (ICAM-1)), eBioL31 (anti-CD207), RB6-8C5
(anti-Gr-1), 4B12 (anti-CCR7)(eBioscience, San Diego, CA), and
G8.8 (anti-EpCAM) (BioLegend, San Diego, CA) were purchased.
For Langerin (CD207) staining, cells were fixed and permea-
bilized with cytofix/cytoperm solution (BD Biosciences, San Jose,
CA), and stained with biotin-conjugated anti-Langerin Ab. Cells
were analyzed with FACSCantoII (BD, Franklin Lakes, NJ).
Histology and immunohistochemistry
Hematoxylin-eosin and toluidine blue staining [31], and the
histological scoring were evaluated as reported [19]. In brief,
samples were scored for the severity and character of the
inflammatory response using a subjective grading scale. Responses
were graded as follows: 0, no response; 1, minimal response; 2,
mild response; 3, moderate response; and 4, marked response. The
slides were blinded, randomized, and reread to determine the
histology score. All studies were read by the same pathologist using
the same subjective grading scale. The total histology score was
calculated as the sum of scores, including inflammation,
neutrophils, mononuclear cells, edema, and epithelial hyperplasia.
For immunohistochemistry, cryosections were fixed in acetone,
incubated with hamster anti–mouse CD11c (eBioscience) followed
by goat anti–hamster AlexaFluor488 (Invitrogen, Carlsbad, CA),
and were subsequently incubated with PE-conjugated anti–mouse
FceRIa (eBioscience). Fluorescence images with DAPI staining
were obtained using a BIOREVO BZ-9000 system (Keyence,
Osaka, Japan).
Quantitative PCR analysis
Total RNAs were isolated with Trizol (Invitrogen) from ear
skin. cDNA was reverse transcribed using a PrimeScript RT
reagent kit (Takara Bio, Otsu, Japan). Quantitative RT-PCR with
a Light Cycler real time PCR apparatus was performed (Roche
Diagnostics, Foster City, CA) using SYBR Green I (Takara Bio).
Primers for Ifng, Il17, and Il1b were obtained from Hokkaido
System Science (Sapporo, Japan) and the primer sequences were
Ifng, 59- ATG AAC GCT ACA CAC TGC ATC -39 (Forward)
and 59- CCA TCC TTT TGC CAG TTC CTC -39 (reverse);
Il17,5 9- TTT AAC TCC CTT GGC GCA AAA -39 (forward), 59-
CTT TCC CTC CGC ATT GAC AC -39 (reverse); and Il1b,5 9-
GCA ACT GTT CCT GAA CTC AAC T -39 (forward), 59- ATC
TTT TGG GGT CCG TCA ACT -39 (reverse). For each sample,
triplicate test reactions and a control reaction lacking reverse
transcriptase were analyzed for expression of the genes and results
were normalized to those of the ‘housekeeping’ glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) levels.
Lymphocyte proliferation assay and cytokine production
For DNBS-dependent proliferation, single-cell suspensions from
skin-draining LNs of mice 5 days after sensitization with DNFB.
One million LN cells were cultured with or without 100 mg/ml of
DNBS for 72 h, pulsed with 0.5 mCi 3H-thymidine for the last
24 h, and subjected to liquid scintillation counting.
For measurement of cytokine production, the culture superna-
tants were collected 72 h after incubation and were measured by
ELISA (BD Biosciences and R&D systems, Minneapolis, MN)
according to the manufacture’s protocol.
CHS protocol
Mice were sensitized with 50 ml of 0.5% (w/v) DNFB in
acetone/olive oil (4/1) or 2% oxazolone (Wako Pure Chemical
Industries, Ltd, Osaka, Japan) in ethanol on abdominal skin. On
day 5, the ears were challenged by application of 20 ml of 0.3%
DNFB or 1% oxazolone.
For adoptive transfer, LN cells were prepared from the inguinal
and axillary LNs of one mouse sensitized with DNFB 5 days
previously, and transferred intravenously into a mouse. The ears of
these animals were challenged with 20 ml of 0.3% DNFB 1 h later,
and the ear thickness change was measured. For adoptive transfer
of T cells, T cells purified with CD90.2
+ microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany) were prepared from the
inguinal and axillary LNs of a mouse sensitized with 2% oxazolone
5 days previously, and transferred intravenously into a mouse. The
ears of these animals were challenged with 20 ml of 1% oxazolone
1 h later, and the ear thickness change was measured.
Generation of BMDC and BMMC
Complete RPMI (cRPMI), RPMI 1640 medium (Sigma, St.
Louis, MO) containing 10% fetal calf serum (Invitrogen), was used
as culture medium. For BMDC induction, 5610
6 BM cells were
cultured supplemented with 10 ng/ml recombinant murine GM-
CSF (PeproTech, Rocky Hill, NJ) for five days [20] (.90%
expressed CD11c).
For BMMC induction, 1610
6 BM cells were cultured
supplemented with 5 ng/ml recombinant murine SCF and IL-3
(PeproTech) for more than three weeks (.98% expressed c-kit and
FceRIa).
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withcartilage,andthedorsalearskinwithoutcartilagewasfloatedin
a dermal side-down manner in 24-well tissue culture plates. Twenty-
four hours later, the cells in the wells were collected for analysis.
Chemotaxis assay and FITC-induced cutaneous DC
migration
Cells were tested for transmigration to CCL21 (R&D Systems)
or medium in the lower chamber across uncoated 5-mm transwell
filters (Corning Costar Corp., Corning, NY) for 6 h and were
enumerated by flow cytometry.
For FITC-induced cutaneous DC migration, mice were painted
on the shaved abdomen with 100 ml of 2% FITC (Sigma) dissolved
in a 1:1 (v/v) acetone/dibutyl phthalate (Sigma) mixture, and the
number of migrated cutaneous DCs into draining LNs was
enumerated by flow cytometry.
Co-culture of BMDCs and BMMCs
BMDCs and starved BMMCs were co-cultured at a density of
2610
5 DCs in 200 ml per well in a 96-well microplate at a
DC:MC ratio of 2:1 and the co-culture was performed for 24 h.
Separation of BMDCs and BMMCs was performed by using
transwell culture plates with a 3-mm pore size (Costar, Corning).
To observe cell-cell contact in vitro, BMDCs and BMMCs were co-
cultured on poly-L-lysine coated glass coverslips (ASAHI GLASS
Co., LTD, Tokyo, Japan) for 24 h and stained with FITC-
conjugated anti-c-Kit and PE-conjugated anti-MHC class II.
For inhibition assays, BMDCs and starved BMMCs were co-
cultured with or without 5 mg/ml of isotype control Ab (Rat
IgG2b, eBioscience), 20 mg/ml of anti-ICAM-1 Ab (YN1/1.7.4,
eBioscience) or 5 mg/ml of anti-TNF-a Ab (MP6-XT22,
eBioscience) for 24 h. Starved BMMCs were pretreated with or
without wortmannin (100 nM; Sigma) or H89 (10 mM; Sigma) for
1 h and then co-cultured with BMDCs for 24 h.
For detection of membrane-bound TNF-a, starved BMMCs
were cultured for 24 h with or without non-stimulated or
stimulated BMDCs with 100 ng/ml of LPS (Sigma) and 50 ng/
ml of CCL21 (R&D systems) for 1 h.
Cytoplasmic Ca
2+ imaging
BMMCs were incubated with 5 mM Quest Fluo-8 AM (ABD
Bioquest, CA, USA), and BMDCs were stimulated with 100 ng/
ml of LPS and 50 ng/ml of CCL21 for 1 h and stained with
2.5 nM tetramethylrhodamine ethyl ester (TMRE) (Invitrogen).
The Fluo-8 image and the transmission image were recorded every
10 sec using a back-thinned electron multiplier CCD camera
(ImagEM, Hamamatsu Photonics, Japan) and microscope (Eclipse
Ti, Nikon, Japan). The fluorescence intensity was expressed as a
ratio to the initial value after subtracting background fluorescence.
Statistical analysis
Unless otherwise indicated, data are presented as the means 6
standard deviation (SD) and are a representative of three
independent experiments. P-values were calculated with the two-
tailed Student’s t-test or one-way ANOVA followed by the
Dunnett multiple comparison test. P values less than 0.05 are
considered to be significantly different between MasTRECK and
corresponding WT mice and are shown as * in the figures.
Supporting Information
Figure S1 EffectofDTonMCinMas-TRECKTgmice. (A)
Skin MCs in Mas-TRECK Tg mice were stained with toluidine
blue with (left panel) or without (right panel) DT treatment. The
numbers of skin MCs in Mas-TRECK Tg mice with or without
DT treatment under steady state or inflammatory conditions (after
24 hours CHS response) are shown (lower). n.d., not detected
(n=5). (B) WT and Mas-TRECK Tg mice (n=5) were treated
with DT, and DCs (CD11c
+), B cells (B220
+), NK cells (DX5
+
FceRI
2), NKT cells (CD3
+DX5
+), CD4




+ T cells (CD3
+CD8
+), eosinophils and neutrophils (Gr-1
+)
were obtained from PBMCs 12 days later (left). WT and Mas-
TRECK Tg mice (n=5) were treated with DT, and the numbers
of basophils (DX5
+FceRI
+) per ml in PBMCs were evaluated 5
days and 12 days later (right). All data are presented as the mean
6 SD and are representative of three experiments.
(PDF)
Figure S2 CHS responses in Kit
W/Wv and Bas-TRECK
mice. (A) DNFB-induced CHS in WBB6F1-Kit+/+ and
WBB6F1-Kit Kit
W/Wv mice. WBB6F1-Kit+/+ and WBB6F1-Kit
Kit
W/Wv mice were sensitized with or without DNFB and the ear
swelling was measured 24 and 48 h after challenge with DNFB
(n=10 per group). (B) DNFB-induced CHS in DT-treated WT
and Bas-TRECK Tg mice. DT-treated WT and Bas-TRECK Tg
mice were sensitized with or without DNFB and the ear swelling
was measured 24 and 48 h after challenge with DNFB (n=10 per
group). (C) Oxazolone-induced CHS in DT-treated WT and Mas-
TRECK Tg mice. Mice were sensitized with 5% oxazolone and
challenged with 1% oxazolone at the high hapten dose (n=10 per
group). (D) CHS induced by adoptive transfer of CD90.2
+ T cells
from WT and Mas-TRECK Tg mice sensitized with DNFB (n=6
per group). (E) Toluidine blue positive mast cells in the skin with
Mas TRECK Tg mice or B6 wild type mice after one hour
injection of BMMC (n=3). All data are presented as the mean 6
SD and are representative of three experiments.
*, P,0.05 versus a
corresponding group.
(PDF)
Figure S3 Decreased infiltrating cells and cytokines in
the skin of Mas-TRECK Tg mice after challenge. (A) The
numbers of CD4
+ T cells, CD8
+ T cells and neutrophils
(CD45
+Gr-1
high) in DNFB-challenged skin were counted in DT-
treated Mas-TRECK Tg or WT mice (n=5 per group) using flow
cytometry. (B) mRNA levels of IFN-c, IL-17 and IL-1b in the skin
after CHS (n=5 per group). All data are presented as the mean 6
SD and are representative of three experiments.
(PDF)
Figure S4 Impaired development of the Th1 subset in
CHS and decreased cytokine production in the LN of
sensitized Mas-TRECK Tg mice. (A) Skin-draining LN cells
were collected from MaS TRECK Tg and WT mice 5 days after
DNFB application. The numbers of CD44
highCD62L
+central
memory (CM) or CD44
highCD62L
2 effector memory (EM) cells
and total CD4
+ and CD8
+ T cells in the draining LNs with or
without sensitization are shown. (B-D) DNBS-induced lymphocyte
proliferation (B) and cytokine production (C, D). Cells were
collected from MaS TRECK Tg and WT mice 5 days after DNFB
application and cultured for 3 days with or without 100 mg/mL
DNBS. Cell proliferation was measured by
3H-thymidine
incorporation. The amounts of IFN-c and IL-17 in the culture
medium were measured by ELISA. n=10 mice per group.
(PDF)
Figure S5 Attenuated DC maturation in the absence of
MCs. (A) Representative flow cytometry profiles of the skin from
WT and Mas TRECK Tg mice (left), and histogram of CD40
expression on LCs and dDCs from DT-treated WT mice and
Mas-TRECK Tg mice treated with or without DT. (B) The
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the ear skin from WBB6F1-Kit+/+,– Kit
W/Wv,WT, and Mas-
TRECK Tg mice under steady state conditions.
(PDF)
Figure S6 timulation of DCs by MCs is dependent on
ICAM-1-LFA-1 interaction and on MC membrane-bound
TNF-a. (A, B) Histogram. The expression levels of CD40 on
BMDCs co-cultured with BMMCs with isotype control Ab, anti-
ICAM-1 Ab, or anti-TNF-a Ab (TNF) (A), or co-cultured with
BMMCs that were pretreated with or without wortmannin (WM)
or H89 (B). (C) The expression levels of CD40, CD80, and CD86
on BMDCs co-cultured with WT derived BMMCs or TNF-a KO
(TNF KO) derived BMMCs.
(PDF)
Video S1 Quest Fluo-8 AM-stained BMMCs and TMRE-
stained BMMCs were mixed on glass coverslips and
recorded every 10 sec at ,306C using a back-thinned
electron multiplier CCD camera.
(MOV)
Video S2 Quest Fluo-8 AM-stained BMMCs and TMRE-
stained stimulated BMMCs were mixed on glass cover-
slips and recorded every 10 sec at ,306C using a back-
thinned electron multiplier CCD camera.
(MOV)
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